Dublin, Feb. 11, 2019 (GLOBE NEWSWIRE) The "Global Smart Inhalers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.
The global smart inhalers market was valued at US$ 1,006.6 Mn in 2017 and is expected to reach US$ 3,674.6 Mn by 2026, expanding at a CAGR of 15.7% from 2018 to 2026.
Metered dose inhalers (MDIs) are the leading type segment for smart inhalers market. Excellent PK/PD profile achieved during the drug delivery and increasing demand in geriatric patients suffering from chronic illness drive the metered dose inhalers market growth. Dry powder inhalers have gained tremendous attraction in recent times due to the drug irritation and severe adverse effects caused by the propellants employed in MDIs. Nebulizers are widely employed in pediatric patients due to higher safety and efficacy associated with the drug delivery system.
Chronic obstructive pulmonary disease is currently leading the application segment for smart inhalers market. The rampant growth of smokers in developed countries and rising industrialization in developing nation has led to the rise of air pollution and exposure to occupational dust and fumes. Asthma will be the fastest growing market in the near future due to the rising prevalence of hereditary asthma in children and requires immediate symptomatic relief due to constriction of respiratory muscles.
In the present scenario, North America with a share of 38% is leading the regional segment for smart inhalers market. The key features that contribute towards its supremacy are rampant growth in tobacco smokers and domicile of major players such as Propeller Health, Cohero Health, 3M Healthcare etc.
Europe accounts for 29% market share, on account of the increasing number of pediatric patients suffering from asthma and strategic collaboration between pharmaceutical giants and software companies to provide a smart inhaler system. The Asia Pacific with a market share of 20% will be the fastest growing regional segment during the forecast period on account of increasing geriatric patients suffering from chronic pulmonary illness and emergence of local players exerting stringent competition to western giants in smart inhalers market.
Key Market Movements:
- An increasing number of geriatric patients suffering from chronic respiratory illness
- A significant increase in the number of tobacco smokers and rising air pollution
- A recent launch of innovative smart apps and wireless services to enhance drug delivery and patient compliance
Key Topics Covered:
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Smart Inhalers Market: Dynamics and Future Outlook
3.1. Market Overview
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Smart Inhalers Market, by Key Players, 2017
Chapter 4. Global Smart Inhalers Market, by Type
4.2. Metered Dose Inhalers
4.3. Dry Powder Inhalers
Chapter 5. Global Smart Inhalers Market, by Application
5.2. Chronic Obstructive Pulmonary Disease (COPD)
Chapter 6. Global Smart Inhalers Market, by Geography
Chapter 7. Company Profiles
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Adherium Limited
7.3. Cohero Health
7.4. 3M Healthcare
7.5. Opko Health, Inc.
7.6. Propeller Health
7.7. Philips Respironics
7.8. Sensirion AG
7.9. Teva Pharmaceutical Industries Ltd.
7.10. Vectura Group, Plc.
For more information about this report visit https://www.researchandmarkets.com/research/4lf22d/global-smart?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Inhalers and Nebulisers, Respiratory Devices
Source: Research and Markets